Trajenta, film-coated tablets

( ARTG ) TRAJENTA is indicated in adult patients with type 2 diabetes mellitus to improve glycaemic control in conjunction with diet and exercise, as monotherapy when metformin and sulfonylureas are not tolerated, or are contraindicated, or, as add on to metformin, sulfonylureas or metformin plus sulfonylureas, or to insulin (with or without metformin) or, as add on to metformin plus SGLT2 inhibitors.